Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus

Condition:   SLE Interventions:   Drug: ESK-001;   Drug: Placebo Sponsor:   Alumis Inc Recruiting

Source: ClinicalTrials.gov - July 28, 2023 Category: Research Source Type: clinical trials